EricP.WinerMD

PubMed

• Mortality Risks Over 20 Years in Men With Stage I to III Hormone Receptor-Positive Breast Cancer.
  Julieta Leone, Michael J Hassett, Rachel A Freedman, Sara M Tolaney, Noah Graham, Nabihah Tayob, Carlos T Vallejo, Eric P Winer, Nancy U Lin, José P Leone> ;JAMA Oncology. 2024 Feb 29
• HER2 heterogeneity and treatment response-associated profiles in HER2-positive breast cancer in the NCT02326974 clinical trial.
  Zheqi Li, Otto Metzger Filho, Giuseppe Viale, Patrizia dell'Orto, Leila Russo, Marie-Anne Goyette, Avni Kamat, Denise A Yardley, Vandana Gupta Abramson, Carlos L Artea...> ;The Journal of Clinical Investigation. 2024 Feb 1
• TBCRC 039: a phase II study of preoperative ruxolitinib with or without paclitaxel for triple-negative inflammatory breast cancer.
  Filipa Lynce, Laura E Stevens, Zheqi Li, Jane E Brock, Anushree Gulvady, Ying Huang, Faina Nakhlis, Ashka Patel, Jeremy M Force, Tufia C Haddad, Naoto Ueno, Vered Stea...> ;Breast Cancer Research. 2024 Jan 31
• HER2/ERBB2 copy number analysis by targeted next-generation sequencing in breast cancer.
  Xia, D., Kuo, F., Hughes, M., Lindeman, N., Manning, D., Files, J., Strauss, S., Kirkner, G., Mohammed-Abreu, A., Winer, E., Tolaney, S., Lin, N., Dillon, D.> ;American Journal of Clinical Pathology. 2023 Dec 16
• Author Correction: Comprehensive genomic characterization of HER2-low and HER2-0 breast cancer.
  Tarantino, P., Gupta, H., Hughes, M., Files, J., Strauss, S., Kirkner, G., Feeney, A., Li, Y., Garrido-Castro, A., Barroso-Sousa, R., Bychkovsky, B., DiLascio, S., Sho...> ;Nature Communications. 2023 Dec 14
• Abnormal vascular structure and function within brain metastases is linked to pembrolizumab resistance.
  Kim, A., Lou, K., Giobbie-Hurder, A., Chang, K., Gidwani, M., Hoebel, K., Patel, J., Cleveland, M., Singh, P., Bridge, C., Ahmed, S., Bearce, B., Liu, W., Fuster-Garci...> ;Neuro-Oncology. 2023 Dec 9
• Exploring anxiety as an influencing factor of the impact of exercise and mind-body prehabilitation on cognitive functioning among women undergoing breast cancer surgery.
  Knoerl, R., Sannes, T., Giobbie-Hurder, A., Frank, E., McTiernan, A., Irwin, M., Winer, E., Ligibel, J.> ;Journal of Psychosocial Oncology. 2023 Dec 4
• Post-diagnosis weight trajectories and mortality among women with breast cancer.
  Leah S Puklin, Fangyong Li, Brenda Cartmel, Julian Zhao, Donna Spiegelman, Mona Sharifi, Melinda L Irwin, Leah M Ferrucci, Sanft, T., Lisevick, A., Winer, E., Lustberg...> ;NPJ Breast Cancer. 2023 Dec 2
• A randomized phase II study of metronomic cyclophosphamide and methotrexate (CM) with or without bevacizumab in patients with advanced breast cancer.
  Erica L Mayer, Nabihah Tayob, Siyang Ren, Jennifer J Savoie, David R Spigel, Howard A Burris 3rd, Paula D Ryan, Lyndsay N Harris, Eric P Winer, Harold J Burstein> ;Breast Cancer Research and Treatment. 2024 Feb 1
• 1 citations
  Comprehensive genomic characterization of HER2-low and HER2-0 breast cancer.
  Tarantino, P., Gupta, H., Hughes, M., Files, J., Strauss, S., Kirkner, G., Feeney, A., Li, Y., Garrido-Castro, A., Barroso-Sousa, R., Bychkovsky, B., DiLascio, S., Sho...> ;Nature Communications. 2023 Nov 18
• 1 citations
  Immunological and clinicopathological features predict HER2-positive breast cancer prognosis in the neoadjuvant NeoALTTO and CALGB 40601 randomized trials.
  Mattia Rediti, Aranzazu Fernandez-Martinez, David Venet, Françoise Rothé, Katherine A Hoadley, Joel S Parker, Baljit Singh, Jordan D Campbell, Karla V Ballman, David W...> ;Nature Communications. 2023 Nov 3
• Impact of pembrolizumab versus chemotherapy on health-related quality of life in patients with metastatic triple-negative breast cancer: results from the phase 3 rando...
  Peter Schmid, Oleg Lipatov, Seock-Ah Im, Anthony Goncalves, Eva Muñoz-Couselo, Keun Seok Lee, Kenji Tamura, Laura Testa, Isabell Witzel, Shoichiro Ohtani, Nicholas Tur...> ;European Journal of Cancer. 2023 Dec 1
• 1 citations
  Impact of BMI in Patients With Early Hormone Receptor-Positive Breast Cancer Receiving Endocrine Therapy With or Without Palbociclib in the PALLAS Trial.
  Georg Pfeiler, Dominik Hlauschek, Erica L Mayer, Christine Deutschmann, Stephanie Kacerovsky-Strobl, Miguel Martin, Jane Lowe Meisel, Nicholas Zdenkowski, Sibylle Loib...> ;Journal of Clinical Oncology. 2023 Nov 20
• 5 citations
  Pembrolizumab in brain metastases of diverse histologies: phase 2 trial results.
  Priscilla K Brastianos, Albert E Kim, Anita Giobbie-Hurder, Eudocia Q Lee, Nancy U Lin, Beth Overmoyer, Patrick Y Wen, Lakshmi Nayak, Justine V Cohen, Jorg Dietrich, A...> ;Nature Medicine. 2023 Jul 1
• 1 citations
  Rekindling Joy in Medicine Through Thoughtful Communication: A Practical Guide.
  Tara Sanft, Eric Winer> ;American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting. 2023 Jun 1
• 8 citations
  Assessment of the HER2DX Assay in Patients With ERBB2-Positive Breast Cancer Treated With Neoadjuvant Paclitaxel, Trastuzumab, and Pertuzumab.
  Waks, A., Ogayo, E., Paré, L., Marín-Aguilera, M., Brasó-Maristany, F., Galván, P., Castillo, O., Martínez-Sáez, O., Vivancos, A., Villagrasa, P., Villacampa, G., Tara...> ;JAMA Oncology. 2023 Jun 1
• Estimating mortality in women with triple-negative breast cancer: The 'ESTIMATE triple-negative' tool.
  José P Leone, Noah Graham, Julieta Leone, Sara M Tolaney, Bernardo A Leone, Rachel A Freedman, Michael J Hassett, Carlos T Vallejo, Eric P Winer, Nancy U Lin, Nabihah ...> ;European Journal of Cancer. 2023 Aug 1
• Extended adjuvant endocrine therapy in a longitudinal cohort of young breast cancer survivors.
  Tal Sella, Yue Zheng, Shoshana M Rosenberg, Kathryn J Ruddy, Shari I Gelber, Rulla M Tamimi, Jeffrey M Peppercorn, Lidia Schapira, Virginia F Borges, Steven E Come, Li...> ;NPJ Breast Cancer. 2023 Apr 25
• 9 citations
  Association Between Biomarkers and Clinical Outcomes of Pembrolizumab Monotherapy in Patients With Metastatic Triple-Negative Breast Cancer: KEYNOTE-086 Exploratory An...
  Sherene Loi, Roberto Salgado, Peter Schmid, Javier Cortes, David W Cescon, Eric P Winer, Deborah L Toppmeyer, Hope S Rugo, Michelino De Laurentiis, Rita Nanda, Hiroji ...> ;JCO Precision Oncology. 2023 Apr 1
• 3 citations
  Circulating tumor DNA association with residual cancer burden after neoadjuvant chemotherapy in triple-negative breast cancer in TBCRC 030.
  Heather A Parsons, Timothy Blewett, Xiangying Chu, Sainetra Sridhar, Katheryn Santos, Kan Xiong, Vandana G Abramson, Ashka Patel, Ju Cheng, Adam Brufsky, Justin Rhoade...> ;Medrxiv. 2023 Mar 8
• 34 citations
  Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer: final 10-year analysis of the open-label, single-arm, phase 2 APT trial.
  Tolaney, S., Tarantino, P., Graham, N., Tayob, N., Parè, L., Villacampa, G., Dang, C., Yardley, D., Moy, B., Marcom, P., Albain, K., Rugo, H., Ellis, M., Shapira, I., ...> ;The Lancet. Oncology. 2023 Mar 1
• 1 citations
  Diet and physical activity interventions in Black and Latina women with breast cancer: A scoping review.
  Margaret S Pichardo, Tara Sanft, Leah M Ferrucci, Yaideliz M Romero-Ramos, Brenda Cartmel, Maura Harrigan, Ana I Velazquez, Oluwadamilola M Fayanju, Eric P Winer, Meli...> ;Frontiers in Oncology. 2023 Jan 1
• 2 citations
  Survival in male breast cancer over the past 3 decades.
  José P Leone, Rachel A Freedman, Julieta Leone, Sara M Tolaney, Carlos T Vallejo, Bernardo A Leone, Eric P Winer, Nancy U Lin, Michael J Hassett> ;Journal of the National Cancer Institute. 2023 Apr 11
• 23 citations
  Adjuvant Exemestane With Ovarian Suppression in Premenopausal Breast Cancer: Long-Term Follow-Up of the Combined TEXT and SOFT Trials.
  Olivia Pagani, Barbara A Walley, Gini F Fleming, Marco Colleoni, István Láng, Henry L Gomez, Carlo Tondini, Harold J Burstein, Matthew P Goetz, Eva M Ciruelos, Vered S...> ;Journal of Clinical Oncology. 2023 Mar 1
• 12 citations
  Adjuvant Endocrine Therapy in Premenopausal Breast Cancer: 12-Year Results From SOFT.
  Prudence A Francis, Gini F Fleming, István Láng, Eva M Ciruelos, Hervé R Bonnefoi, Meritxell Bellet, Antonio Bernardo, Miguel A Climent, Silvana Martino, Begoña Bermej...> ;Journal of Clinical Oncology. 2023 Mar 1
• Join now to see all

Journal Articles

• Individualizing Surveillance Mammography for Older Patients After Treatment for Early-Stage Breast Cancer  
  Eric P Winer, Louise C Walter, Mina S Sedrak, Tanya M Wildes, Stuart M Lichtman, Kathryn J Ruddy, JAMA Oncology
• Effect of Eribulin with or Without Pembrolizumab on Progression-Free Survival for Patients with Hormone Receptor–Positive, ERBB2-Negative Metastatic Breast Cancer  
  Sara M Tolaney, Gerburg Wulf, Laura Spring, Beth Overmoyer, Ann H Partridge, Eric P Winer, Ian E Krop, JAMA Oncology
• Pembrolizumab Monotherapy for Previously Untreated, PD-L1-Positive, Metastatic Triple-Negative Breast Cancer: Cohort B of the Phase II KEYNOTE-086 Study  
  M C Liu, R Nanda, H S Rugo, E P Winer, S Adams, Annals of Oncology
• Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer  
  Amreen Husain, Sylvia Adams, Hope S Rugo, Carlos H Barrios, Eric P Winer, The New England Journal of Medicine
• Join now to see all

Lectures

• Breast Cancer, New Horizons, Current Controversies 
  Harvard Medical School, Boston, Massachusetts - 7/11/2013
• 35th Annual CTRC-AACR San Antonio Breast Cancer Symposium(SABCS) 
  UT Health Science Center San Antonio, San Antonio, Texas - 12/4/2012
• Breast Cancer, New Horizons, Current Controversies 
  Harvard Medical School, Boston, Massachusetts - 7/12/2012